Duram Pharmachem Profile
Key Indicators
- Authorised Capital ₹ 1.00 Cr
- Paid Up Capital ₹ 1.00 Cr
- Company Age 30 Year, 3 Months
- Last Filing with ROC 31 Mar 2024
- Satisfied Charges ₹ 11.10 Cr
- Revenue Growth -37.65%
- Profit Growth 19.35%
- Ebitda -6.25%
- Net Worth -14.18%
- Total Assets 0.20%
About Duram Pharmachem
Duram Pharmachem Private Limited (DPPL) is a Private Limited Indian Non-Government Company incorporated in India on 28 October 1994 and has a history of 30 years and three months. Its registered office is in Mumbai, Maharashtra, India.
The Corporate was formerly known as Dura Holdings Private Limited. The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 1.00 Cr and a paid-up capital of Rs 1.00 Cr.
The company has closed loans amounting to ₹11.10 Cr, and has no open charges as per Ministry of Corporate Affairs (MCA) records.
Rakesh Doshi and Usha Doshi serve as directors at the Company.
Company Details
- Location
Mumbai, Maharashtra, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
- Social Media
Corporate Identity Details
- CIN/LLPIN
U65990MH1994PTC082503
- Company No.
082503
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
28 Oct 1994
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Mumbai
Industry
Who are the key members and board of directors at Duram Pharmachem?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Rakesh Doshi  | Director | 28-Oct-1994 | Current |
| Usha Doshi | Director | 28-Oct-1994 | Current |
Financial Performance of Duram Pharmachem.
Duram Pharmachem Private Limited, for the financial year ended 2021, experienced significant reduction in revenue, with a 37.65% decrease. The company also saw a substantial improvement in profitability, with a 19.35% increase in profit. The company's net worth observed a substantial decline by a decrease of 14.18%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Duram Pharmachem?
In 2021, Duram Pharmachem had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Kopran Research Laboratories LimitedRakesh Doshi is a mutual person
Charges (Loans)
₹0
₹11.10 Cr
Charges Breakdown by Lending Institutions
- Sicom Investments & Finance Limited : 10.00 Cr
- State Bank Of India : 1.10 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 30 Aug 2012 | Sicom Investments & Finance Limited | ₹10.00 Cr | Satisfied |
| 14 Jan 2011 | State Bank Of India | ₹1.10 Cr | Satisfied |
How Many Employees Work at Duram Pharmachem?
Duram Pharmachem has a workforce of 15 employees as of Apr 09, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Duram Pharmachem, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Duram Pharmachem's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.